Clinical Trial Update: Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus [Phase 4]

View source ↗

Summary

This open-label Phase 4 trial of Acthar Gel in adults with moderate to severe active systemic lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Fiechtner, Justus J., M.D., P.C. | Conditions: Lupus Erythematosus Systemic Exacerbation | Phase 4 | Status: COMPLETED